Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > EV / EBITDA (ntm)

Adverum Biotechnlgs EV / EBITDA (ntm) Chart (ADVM)

Adverum Biotechnlgs annual/quarterly EV / EBITDA (ntm) from 2020 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • Adverum Biotechnlgs Market Cap for the quarter ending March 03, 2018 was $361m a 70.28% increase of 253m year over year
  • Adverum Biotechnlgs Price / Book for the quarter ending March 03, 2018 was 1.54 a 65.62% increase of 1.01 year over year
  • Adverum Biotechnlgs Enterprise Value for the quarter ending March 03, 2018 was $170m a 160.05% increase of 273m year over year
View Chart On Koyfin